Patient using an accessible pharmaceutical website with features for readable text, keyboard navigation, captions, and screen readers.

Can Every Patient Actually Use Your Pharma Website?

It’s easy to treat pharma website accessibility as little more than a technical checklist. Yet for patients, the questions are much more basic: Can...
FDA Complete Response Letter on a pharmaceutical regulatory desk with clinical data and drug application documents

Your Drug Didn’t Get Approved. Now the FDA Can Tell Everyone Why.

The communications playbook for a failed drug approval has changed. Complete Response Letters, or CRLs, once remained largely between the FDA and drug sponsors....
Nurse practitioner and physician assistant reviewing digital clinical information as part of an APP pharma marketing strategy.

Stop Treating APPs Like Doctors: The Audience Pharma Keeps Underserving

Pharma marketing has a growing APP audience problem. Nurse practitioners (NPs), physician assistants/associates (PAs), and other advanced practice providers (APPs) now play major roles...
Global pharmaceutical pricing dominoes illustrate how MFN drug pricing in international markets could influence US drug prices and launch strategy.

The Global Pricing Domino Effect: Could One Market Reshape Your US Launch?

The expansion of MFN drug pricing is changing a basic assumption behind pharmaceutical commercialization: a pricing decision made in one country may no longer...
FDA SIUU guidance materials illustrating scientific information on unapproved uses and pharmaceutical communications with healthcare professionals.

Off-Label or On-Target? Inside Pharma’s New SIUU Playbook

The FDA SIUU guidance gives pharmaceutical companies a more defined framework for certain firm-initiated scientific communications about unapproved uses. Finalized in January 2025, the...
Pharma marketer reviewing healthcare tracking pixels, patient data privacy, and secure digital measurement on a laptop.

Your Pharma Website Is Still Tracking Patients. Now What?

Healthcare tracking pixels have become a growing privacy concern for pharmaceutical marketers. Pixels and other tracking tools once treated as routine parts of digital...
Hourglass illustrating the IRA small molecule nine-year timeline compared with the 13-year biologics timeline for Medicare drug price negotiations.

Nine Years or Thirteen? The IRA Timeline That’s Changing Pharma Marketing Forever

The Inflation Reduction Act (IRA) has changed more than drug pricing. It is changing the commercial clock for pharmaceutical brands. For small-molecule drugs, Medicare...
Patient using a neuroinclusive healthcare app with clear navigation, flexible reminders, and accessible patient support features.

Neuroinclusive Patient App UX: Designing for Every Mind

Patient support apps are designed to make healthcare easier. Yet what happens when the app itself becomes another barrier? For people with ADHD, autism,...
Discover how AI voice localization in pharma can scale KOL medical education worldwide while protecting consent, compliance, transparency, and trust.

AI Voice Localization in Pharma: One KOL, Fifty Languages

A respected key opinion leader delivers a compelling medical presentation in English. Now imagine that same expert appearing to deliver it naturally in Spanish,...

Inside THCP2026: How Pharma Is Rethinking Transparency, HCP Engagement and Compliance

Pharma and life sciences companies are navigating an increasingly complex challenge: engaging healthcare professionals in ways that deliver genuine educational and clinical...